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Abstract
Background: Few studies have identified the willingness rate of developing countries population to be enrolled in
clinical trials.
Methods: All participants including patients (n = 612), healthy volunteers (n = 354) and doctors (n = 134) completed
a questionnaire to examine factors affecting the consent to participate in medical research.
Results: Overall, 80 % of the included population agree to participate in health research. This rate was lower for
trials dealing with life-threatening diseases (38 %). Altruism and perceived risk of harm were the main reason to
respectively accept or refuse to participate in clinical trials. Factors significantly associated with willingness were:
age <40 years (Odds Ratio (OR) 1.6 [95 % Confidence Interval (CI) 1.2-2.1]) and prior history of blood donation (OR
2.4 [95 % CI 1.7-3.5]).
Conclusion: Most participants expressed their willingness to be included in medical research especially if they are
young or if they have history of blood donation. However, consent to participate is low when medical research
required acute care.
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Background
In the past decade, there is a growing trend in designing
big trials that integrate many thousands of persons with
possibility of using different data sources [1–3]. How-
ever, many observers noted the underrepresentation of
patients from developing countries in these trials, espe-
cially Muslim communities which raises concerns about
the generalizability of their results [4, 5]. Socio-cultural
factors like illiteracy, logistical barriers, and distrust in
clinical research may influence people’s decision to par-
ticipate in biomedical research and possibly limit the
rate of consent [6–9]. To our knowledge, there is no
study that assessed the willingness of Muslim and Arab
communities to participate in individual research trials.
The purpose of our study was to evaluate willingness to
participate in medical research in a Tunisian population,
and determine factors that could influence their consent.
Methods
This is a transversal survey performed in the out-
patient clinic of three Tunisian university hospitals
from November 2010 to February 2011. Participants
were screened for inclusion on the basis of conveni-
ence sampling. Potential participants in our survey
were recruited either as patients waiting for their clinic
appointments or as healthy volunteers accompanying
their relatives. Both medical and surgical patients were
recruited. Most medical patients were from cardiology,
endocrinology and rheumatology clinics. We also in-
cluded a sample of doctors working in the participating
hospitals. Most of them (92 %) are specialist senior in their
disciplines (emergency department, cardiology, pneumol-
ogy, anesthesiology, internal medicine, surgery, pedia-
try…). We used a face-to-face questionnaire (Additional
file 1) and the answers were recorded by one of the inves-
tigators who gave information about the survey and the
questionnaire. Exclusion criteria were acutely ill patients,
persons under 18 years, persons who choose not or unable
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to participate and those who came to the hospital during
the weekend.
The survey tool consisted of open-ended questions con-
ducted in Arabic language. The questionnaire assessed the
attitudes of the individuals regarding some items: willing-
ness to participate in clinical trials, reason for acceptance,
reasons for refusal, attitude towards the enrollment of a
very sick relative in medical research, and opinion about
investigator’s main goals behind doing research.
For all participants included in the study, demographic
data were collected and stored on a standard clinical rec-
ord form. These included age, sex, marital status, educa-
tional level, morbidity, prior participation in a medical
research and history of blood donation. The questionnaire
was anonymous.
Data analysis
Continuous variables were expressed as means and
standard deviations when they were normally distributed
and as medians (95 % confidence interval) when they
were not normally distributed. Continuous variables
were compared using one way ANOVA Test or Kruskal-
Wallis test depending on the validity conditions of each
test. Categorical variables were compared using the chi-
squared test or Fisher’s exact test, as appropriate. To
examine the factors that possibly influence participant
willingness, a multiple logistic regression analysis was
performed. Acceptance to participate was the dependent
variable and the independent variables were included in
the model at the risk of 20 %. The difference is consid-
ered statistically significant only for values of p ≤ 0.05.
The data obtained in this study were collected, stored
and analyzed using SPSS (version 18.00).
Results
During the study period, 1201 participants were in-
cluded and 1100 completed the questionnaire (comple-
tion rate 91.6 %). We included 612 in patients group
(56 %), 354 in healthy volunteers group (32 %) and 134
in doctors’ group (12 %). Overall, 676 (61 %) were youn-
ger than 40 years, 21 % had no co-morbidities, and
34.5 % had a previous history of blood donation. Demo-
graphic of study participants characteristics are de-
scribed in Table 1. Mean age was lowest in volunteers
group while patients group had the highest proportion
of married and the lowest rate of high education level.
Doctors group had the highest proportion of history of
prior participation in medical research and blood dona-
tion. Our results reported 80 % overall rate of willing-
ness to participate in medical research but this rate was
lower when the research concerns a life-threatening situ-
ation (38 %). Rate of willingness was significantly higher
in doctors’ group compared to patients and volunteers
(Fig. 1). Altruism and contribution to health care
improvement were the common reasons for participa-
tion acceptance. In fact, 40 % of patients accept to be
enrolled in a medical research bearing in mind the im-
portance of taking part in health care improvement. Per-
ceived risk of harm was the major reason for refusal
(66 %) and only 6 % of participants think that medical
research are useless (Table 2). Healthy volunteers, young
participants (<40 years), high education level, presence
of chronic disease and prior history of blood donation
were associated with willingness to participate in a med-
ical research (Table 3). The independent factors were
young participant (age < 40 years) and history of blood
donation (OR 1.6 [95 % CI 1.2-2.1] and 2.4 [95 % CI
1.7-3.5] respectively). There was a general positive
opinion about the intention of the investigators leading
studies. The majority of respondents in particular pa-
tients group believe in the aim of finding new treat-
ments (70.6 %), and enlarging knowledge with medical
research (65.2 %). Difference between patients and the
two other groups was significant (p = 0.001). Improving
investigator’s career and earning money were consid-
ered less important as motivation to conduct medical
research (Fig. 2).
Discussion
The main result of our study was the positive attitude
toward medical research in our population with a high
rate (80 %) of willingness to participate especially in
medical doctors group (89 %). Altruism and the desire








Age mean years (SD) 42.3 (15.8) 25.9 (9.8)* 35.6 (9.5)
Sex Male n (%) 196 (32) 131 (37) 60 (45)**
Married n (%) 447 (73) 123 (29)* 86 (64)
History of chronic disease n (%) 213 (35) 42 (12) 22 (16)
arterial hypertension 105 19 9
diabetes 72 18 10




rheumatic disease 18 9 1
neoplasia 10 0 0
others 5 11 7
High school education n (%) 318 (52) 244 (69) 134 (100)**
Prior participation in medical
research n (%)
24 (4) 28 (8) 32 (24)**
History of previous blood
donation n (%)
184 (30) 124 (35) 68 (51)**
*p < 0.05 vs patients and doctors groups. **p < 0.05 vs patients and
volunteers groups
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to contribute to medical care improvement were the
main motivation for participation while risk of harmful
effects and distrust were the main reason for refusal.
The independent factors associated with willingness
were age <40 years and history of blood donation.
The progress of medicine today is a result of biomed-
ical research which necessarily involves human partici-
pants. The adequate representation of racial and ethnic
minorities in clinical trials is required to reach meaning-
ful results. This issue is of great importance for the rele-
vance of international trials involving many countries.
However, most research participants in available trials
continue to be recruited from USA and Europe while
those from developing countries especially from Muslim
communities continue to be underrepresented [4]. Dif-
ferences related to socioeconomic status, ethnicity, and
education may constitute a limit to their participation.
In areas with low literacy level and population unfamiliar
with research concepts recruiting subjects to medical tri-
als is a big challenge. Unexpectedly, we found a high rate
of willingness in our study population. This could be re-
lated to the trust of our population towards their doc-
tors. Experience has shown that paternalism model
where doctors’ opinions are accorded a larger role in
decision-making is an accepted pattern of informed con-
sent in such settings. Our results were similar to many
studies performed in developed countries such America,
Denmark, England, Belgium and France [4, 10–12].
Similarly, in a recent study conducted in Saudi Arabia, it
was demonstrated that a significant number of oncology
patients (61 %) were willing to participate in clinical tri-
als [13]. This means that in Arab and Muslim regions
patient’s awareness and perception of medical research
are not limiting factor in clinical trials recruitment. In
contrast, a low rate of consent was reported in Japanese
population [14] which means that ethnicity and race are
two unmodified factors that may influence attitude to re-
search. The same findings were observed with African
and Latin Americans where the lack of participation is
partly explained by the level of suspicion and mistrust
among minority communities regarding their participa-
tion in medical research [5, 15, 16]. It should be
highlighted that consent to participate to medical re-
search depends also on individual factors. For example,
more educated patients may have a better understanding
of the social benefits of clinical research. Available stud-
ies showed that middle-aged patients and those with a
favorable experience of health care may be more willing
to participate [17]. In our study, we found that young
age, high school education level, and prior history of
blood donation were associated with better acceptance
of taking part to biomedical research. Altruism was a
Fig. 1 Rate of willingness to participate in medical research (solid bars) and research dealing with critically ill patients (open bars). No statistically
significant difference between groups
Table 2 Reasons for acceptance or refusal to participate in medical
research for the overall population
n (%)
Reasons for acceptance n = 891
Altruism 356 (33.3)
Health care improvement 356 (33.3)
Help patients 44 (4.9)
Other reasons 153 (28.5)
Reasons for refusal n = 209
Risk of harmful effects 138 (66.0)
Distrust 44 (21.0)
Researchs are useless 12 (5.7)
Others reasons 15 (7.3)
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common reason to accept participation to medical re-
search in our population. In previous studies [11, 18, 19]
receiving personal benefits like better treatment [20] was
also highlighted. The main reason for refusal to partici-
pate in medical research in our study was the fear of side
effects; this concern was found in other surveys [21].
Obviously, none would participate in research activities
unless they feel safe and are treated with dignity and
trust [13, 15, 22, 23]. Factors related to research method-
ology could also influence the response attitude. It was
demonstrated that randomization and blinding can
cause anxiety, discomfort, and confusion among partici-
pants [21]. This is also common in medical emergency
situations and can cause a significant impediment to the
conduct of clinical trials including critically ill patients.
The vulnerable nature of critically ill patients raises is-
sues of patient safety, and consent to participate in clin-
ical trial could be difficult. Our results support this
feeling in demonstrating fear of our population from the
potential incremental risk posed by participation in in-
tensive care research. Would different results have been
obtained if the survey had been conducted under real
life conditions? The answer to this question is not obvi-
ous with regard to the nature and complexity of urgent
decision in presence of devastating illness that makes
objective evaluation of the informed consent process dif-
ficult. Whatever the willingness rate in this setting, it is
essential that the health care professionals recruiting re-
search participants are well trained in order to provide
comprehensive information and obtain the required
trust. Researchers trust is an important factor in willing-
ness process and may explain the high rate observed in
our study. In support to these findings the positive be-
lieve at our participants with regard to the main object-
ive of investigators in conducting research.
There were limitations to this study. First, our study
assessed the attitude toward medical research in general
and so, the participants can feel themselves less con-
cerned and probably more enthusiastic to participate
than they are really. Their opinions were an intention
more than an effective decision. Second, our sample was
limited to those who agreed to participate in this study
and probably it represents who are more willing to par-
ticipate. Third, our study focused on overall clinical trial
participation. Our search did not specify whether the
willingness could be different in observational versus
interventional study. Fourth, in this survey we assessed
Table 3 Comparison between survey participants who accept
and who do not accept to participate in medical research
Accept to participate
Yes n = 891 No n = 209 p
Participants n (%)
Patients 488 (79.7) 122 (20.31) 0.34
Volunteers 281 (79.3) 73 (20.7)
Doctors 122 (91) 12 (9)
Age < 40 years n (%) 557 (62.5) 109 (52) 0.05
High school education n (%) 622 (70) 80 (38) <0.01
Sex male n (%) 320 (36) 74 (35) 0.89
Not married n (%) 335 (37) 80 (38) 0.85
History of chronic disease n (%) 277 (31) 21 (10) <0.01
Prior participation in medical
research n (%)
75 (8) 6 (3) <0.01
History of blood donation n (%) 335 (37) 46 (22) <0.01
Fig. 2 Main objectives of medical researchers from the point of view of patients, volunteers and doctors. *p < 0.05 between patients vs
volunteers and doctors
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only the participant point of view. As paternalism and
coercion are current model of medical care in our cul-
tural behavior, we need to evaluate the practices among
attending professionals in matters relating to informed
consent to assess objectively its validity when obtained
in such conditions. Fifth, our survey was not designed to
assess willingness to participate in medical research in-
cluding children. This raises specific ethical complexities
that are not under the scope of this study.
Conclusions
Most of the participants in this survey indicated that
they were willing to take part in clinical research in par-
ticular doctors and young people. Our findings are an
important step in remedying any underrepresentation of
Muslim groups in international clinical trials.
Additional file
Additional file 1: Questionnaire. It was anonymous, face-to-face
questionnaire and the answers were recorded by one of the investigators
who gave information about the survey. (DOCX 23 kb)
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